Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Upcoming Events

Calendar Review
JCCC “Leaders in the Field” Seminar Series Featuring Dr. Joseph Costello
The Evolving Genomic Landscape of IDH1 Mutant Tumors
Date: 3/26/2013
Time: 12:00 PM - 1:00 PM
Cost: Free
Location: 73-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095

JCCC SeminarDr. Joseph Costello

Presented by:
Joseph Costello, Ph.D.
Director, Epigenetics Division, Cell Cycling and Signaling Program
Karen Osney Brownstein Endowed Chair in Molecular Neuro-Oncology
University of California, San Francisco

Dr. Costello's laboratory investigates the role of genetic and epigenetic alterations in the development of sporadic cancers, with a focus on brain tumors. Most sporadic cancers have been described by molecular pathways involving gain and loss of chromosomal regions corresponding to oncogene activation and tumor suppressor gene inactivation, respectively. Such genetic characterizations of sporadic tumors do not take into account epigenetic alterations that may similarly result in abnormal loss or gain of gene activity. 

Light lunch served

Sponsored by the JCCC